Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Finasteride may cause depression and suicidal thoughts, especially in young men.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Finasteride for female hair loss has low side effects, more research needed.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Finasteride improves heart function and balance in aging and obese male rats by reducing oxidative stress.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Finasteride shows promise for female hair loss, but more research needed.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.